BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20964203)

  • 1. Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET.
    Lee CL; Wahnishe H; Sayre GA; Cho HM; Kim HJ; Hernandez-Pampaloni M; Hawkins RA; Dannoon SF; VanBrocklin HF; Itsara M; Weiss WA; Yang X; Haas-Kogan DA; Matthay KK; Seo Y
    Med Phys; 2010 Sep; 37(9):4861-7. PubMed ID: 20964203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.
    Seo Y; Gustafson WC; Dannoon SF; Nekritz EA; Lee CL; Murphy ST; VanBrocklin HF; Hernandez-Pampaloni M; Haas-Kogan DA; Weiss WA; Matthay KK
    Mol Imaging Biol; 2012 Dec; 14(6):735-42. PubMed ID: 22382618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution and radiation dosimetry of
    Moraitis A; Jentzen W; Reiter G; Schmitz J; Pöppel TD; Weber M; Herrmann K; Fendler WP; Fragoso Costa P; Bockisch A; Kersting D
    EJNMMI Phys; 2024 Jan; 11(1):3. PubMed ID: 38167953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-specific dosimetry using pretherapy [¹²⁴I]m-iodobenzylguanidine ([¹²⁴I]mIBG) dynamic PET/CT imaging before [¹³¹I]mIBG targeted radionuclide therapy for neuroblastoma.
    Huang SY; Bolch WE; Lee C; Van Brocklin HF; Pampaloni MH; Hawkins RA; Sznewajs A; DuBois SG; Matthay KK; Seo Y
    Mol Imaging Biol; 2015 Apr; 17(2):284-94. PubMed ID: 25145966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.
    Matthay KK; Weiss B; Villablanca JG; Maris JM; Yanik GA; Dubois SG; Stubbs J; Groshen S; Tsao-Wei D; Hawkins R; Jackson H; Goodarzian F; Daldrup-Link H; Panigrahy A; Towbin A; Shimada H; Barrett J; Lafrance N; Babich J
    J Nucl Med; 2012 Jul; 53(7):1155-63. PubMed ID: 22700000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human biodistribution and dosimetry of the PET radioligand [¹¹C]flumazenil (FMZ).
    Laymon CM; Narendran R; Mason NS; Carney JP; Lopresti BJ; Mathis CA; Mountz JM; Sashin D; Frankle WG
    Mol Imaging Biol; 2012 Feb; 14(1):115-22. PubMed ID: 21365327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.
    Bretin F; Bahri MA; Bernard C; Warnock G; Aerts J; Mestdagh N; Buchanan T; Otoul C; Koestler F; Mievis F; Giacomelli F; Degueldre C; Hustinx R; Luxen A; Seret A; Plenevaux A; Salmon E
    Mol Imaging Biol; 2015 Aug; 17(4):557-64. PubMed ID: 25595813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 124I-MIBG: a new promising positron-emitting radiopharmaceutical for the evaluation of neuroblastoma.
    Cistaro A; Quartuccio N; Caobelli F; Piccardo A; Paratore R; Coppolino P; Sperandeo A; Arnone G; Ficola U
    Nucl Med Rev Cent East Eur; 2015; 18(2):102-6. PubMed ID: 26315872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technical Note: Simplified and practical pretherapy tumor dosimetry - A feasibility study for
    Seo Y; Huh Y; Huang SY; Hernandez-Pampaloni JM; Hawkins RA; Gustafson WC; Vo KT; Matthay KK
    Med Phys; 2019 May; 46(5):2477-2486. PubMed ID: 30761545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical Incorporation Dosimetry of [
    Sattler B; Kranz M; Wenzel B; Jain NT; Moldovan RP; Toussaint M; Deuther-Conrad W; Ludwig FA; Teodoro R; Sattler T; Sadeghzadeh M; Sabri O; Brust P
    Molecules; 2020 Apr; 25(9):. PubMed ID: 32357571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phantom study: Should
    Beijst C; de Keizer B; Lam MGEH; Janssens GO; Tytgat GAM; de Jong HWAM
    Med Phys; 2017 May; 44(5):1624-1631. PubMed ID: 28273347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution and Dosimetry of
    Pandit-Taskar N; Zanzonico P; Staton KD; Carrasquillo JA; Reidy-Lagunes D; Lyashchenko S; Burnazi E; Zhang H; Lewis JS; Blasberg R; Larson SM; Weber WA; Modak S
    J Nucl Med; 2018 Jan; 59(1):147-153. PubMed ID: 28705916
    [No Abstract]   [Full Text] [Related]  

  • 13. PET-Based Human Dosimetry of
    Boss M; Buitinga M; Jansen TJP; Brom M; Visser EP; Gotthardt M
    J Nucl Med; 2020 Jan; 61(1):112-116. PubMed ID: 31519801
    [No Abstract]   [Full Text] [Related]  

  • 14. Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humans.
    Doss M; Kolb HC; Zhang JJ; Bélanger MJ; Stubbs JB; Stabin MG; Hostetler ED; Alpaugh RK; von Mehren M; Walsh JC; Haka M; Mocharla VP; Yu JQ
    J Nucl Med; 2012 May; 53(5):787-95. PubMed ID: 22499613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetry of 64Cu-DOTA-AE105, a PET tracer for uPAR imaging.
    Persson M; El Ali HH; Binderup T; Pfeifer A; Madsen J; Rasmussen P; Kjaer A
    Nucl Med Biol; 2014 Mar; 41(3):290-5. PubMed ID: 24533988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrepant salivary gland response after radioiodine and MIBG therapies.
    Jentzen W; Richter M; Poeppel TD; Schmitz J; Brandau W; Bockisch A; Binse I
    Q J Nucl Med Mol Imaging; 2017 Sep; 61(3):331-339. PubMed ID: 25566809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric 131I-MIBG Therapy for Neuroblastoma: Whole-Body 131I-MIBG Clearance, Radiation Doses to Patients, Family Caregivers, Medical Staff, and Radiation Safety Measures.
    Willegaignon J; Crema KP; Oliveira NC; Pelissoni RA; Coura-Filho GB; Sapienza MT; Buchpiguel CA
    Clin Nucl Med; 2018 Aug; 43(8):572-578. PubMed ID: 29916922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates.
    Quinn B; Dauer Z; Pandit-Taskar N; Schoder H; Dauer LT
    BMC Med Imaging; 2016 Jun; 16(1):41. PubMed ID: 27317478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of radiation dose to patients from (18) FDG whole body PET/CT investigations using dynamic PET scan protocol.
    Kaushik A; Jaimini A; Tripathi M; D'Souza M; Sharma R; Mondal A; Mishra AK; Dwarakanath BS
    Indian J Med Res; 2015 Dec; 142(6):721-31. PubMed ID: 26831421
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Aboian MS; Huang SY; Hernandez-Pampaloni M; Hawkins RA; VanBrocklin HF; Huh Y; Vo KT; Gustafson WC; Matthay KK; Seo Y
    J Nucl Med; 2021 Jan; 62(1):43-47. PubMed ID: 32414950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.